Astigi 2025: Manufacturing Grew, but Distribution and FX Still Set the Picture

Getting to Know the Company

Astigi is neither a pure defense manufacturer nor a plain-vanilla electronic-components distributor. It is a group with two different economic layers: a long-standing distribution business for electronic components and systems, and alongside it a development and manufacturing arm that is trying to shift the center of gravity toward RF, microwave and rugged-computing solutions. In 2025, the second arm is what genuinely worked. Development and manufacturing revenue rose to NIS 43.5 million, segment operating profit jumped to NIS 8.8 million, and segment Adjusted EBITDA, a management metric rather than an IFRS one, reached NIS 12.8 million. Anyone looking only at consolidated revenue of NIS 183.6 million could come away thinking this was another stable year. That is incomplete.

The active bottleneck is that the transition still has not crossed critical mass. Distribution still accounts for about 76% of revenue and about 64% of segment operating profit. So when the shekel strengthened against the dollar and the second half cooled off, the consolidated result weakened fast. Second-half revenue fell 12%, gross profit fell 32%, operating profit fell 73%, and net profit nearly evaporated to NIS 1.2 million. In other words, manufacturing is clearly narrowing the gap, but it still does not run the story on its own.

There is also a real cushion here. Astigi ended the year with NIS 75.3 million of cash, only NIS 5.95 million of bank debt, equity funding 76% of the balance sheet, and NIS 137.1 million of working capital. Close to the report date, total backlog rebounded to NIS 172.7 million after standing at only NIS 145.4 million at year-end. That is a good starting point. The problem is that the quality of cash and backlog is not uniform. The 2025 cash-flow print was helped by a sharp release in receivables, and part of the distribution engine operates through a VMI model where inventory and credit risk remain on Astigi rather than moving to the customer.

There is also a practical screen issue. Control remains concentrated with Shlomo Bar at roughly 67% of the equity, and trading liquidity is thin. In the latest market snapshot, daily turnover was only about NIS 107.8 thousand. So even if the thesis improves, price discovery can still stay uneven.

The Economic Map

Events and Triggers

The first trigger: manufacturing is no longer a side story. The development and manufacturing segment rose 49% in revenue and 182% in operating profit, reaching a 29.4% Adjusted EBITDA margin. This is not just optionality anymore. It is already a meaningful economic engine. But the filing also shows why the market is not ready to give it a full re-rating. In the second half of 2025, the same segment generated only NIS 343 thousand of operating profit, versus NIS 4.1 million in the comparable period. So even after a strong annual jump, quarterly earnings stability is still unproven.

The second trigger: the manufacturing backlog was both rescheduled and reinforced. In one agreement worth about $9.1 million, the customer asked to rephase delivery so that half of the systems would be supplied by the end of 2025 and the remainder by the first half of 2026. At the same time, a follow-on agreement worth $5 million was signed for identical systems. In another agreement, the customer pushed supply timing out to 2030, with roughly 85% of the order, about $14 million, due by the end of 2027. The subsidiary is also expected to receive an additional $2.6 million of advances in the first quarter of 2026, on top of roughly $1.7 million already paid, and the amounts deferred from the original end-2025 schedule, around $6 million net of advances, carry prime interest. That matters because this is not just backlog. It is backlog quality, cash-profile quality and timing risk all at once.

The third trigger: year-end looked weaker than the picture close to publication. Total consolidated backlog fell to NIS 145.4 million at year-end from NIS 164.3 million a year earlier, but close to publication it had already risen to NIS 172.7 million. That gap means the market can easily anchor on the year-end print while the live picture has already improved. But the rebound came mainly from the distribution side, which rose from NIS 69.0 million at year-end to NIS 94.9 million near publication, not from a clean reset in the earnings mix.

The fourth trigger: management depth remains limited. In the compensation disclosure, the scope of key roles is described as part of a narrow management spine, and in 2026 the company is also changing long-time CFOs. Shoshana Bercovitz, who has been with the company since 1994, will leave on May 31, 2026. Shy Hevrony, who has served as the group’s business controller for the past four years and before that was chief accountant at Motorola Solutions Israel, was appointed CFO and company secretary effective May 1, 2026. This looks like an orderly handover, but in a small company with concentrated authority, even an orderly handover is worth tracking.

Efficiency, Profitability and Competition

The central story of 2025 is a paradox. On the operating side, the company describes real activity growth of about 9%. On the reported side, revenue rose only 2%. On the profitability side, operating profit fell 8% and net profit fell 39%. This is not just an accounting wrinkle. It is evidence that Astigi’s cost base is still more shekel-heavy than its revenue base, so what looks like real business growth can be eroded quickly when the dollar weakens.

What Actually Drove the Change

In distribution, real activity was broadly flat versus 2024 according to the company. But that did not translate into reported revenue or profit because the dollar weakened against the shekel while selling, marketing and overhead costs remained mostly shekel-based. The result is that distribution fell to NIS 140.8 million of revenue and NIS 15.9 million of operating profit, from NIS 149.7 million and NIS 23.2 million in 2024. That is a far sharper drop than normal noise in a distribution business.

Manufacturing and development look much better on the surface. Revenue rose to NIS 43.5 million from NIS 30.3 million, and operating profit rose to NIS 8.8 million from NIS 3.7 million. The driver was the shift of new projects into production, faster delivery of some orders received in the second half of 2024, and continued work on new projects. That is the positive core.

But this is exactly where the caution belongs. In the second half, development and manufacturing generated only NIS 343 thousand of operating profit on NIS 19.9 million of revenue. The company attributes that pressure to a mix of shekel appreciation, new hiring, and higher amortization of previously capitalized costs flowing into cost of sales. So the manufacturing engine is growing, but it is still in a stage where additional headcount and project complexity can eat a large part of the operating upside.

The Quality of Growth

Astigi’s growth is not only about segment mix. It is also about concentration. In 2025, two customers alone generated 32% of group revenue, up from 18% in 2024. Customer A by itself rose to NIS 41.3 million, 22% of revenue, versus only 11% a year earlier. Customer C dropped to 9%, but the top three customers together still explain 41% of sales. The company does not disclose their identities, so investors get the number without being able to judge whether the concentration sits with especially strong counterparties or with a weaker concentration profile.

Supplier concentration is also meaningful. Three material suppliers account for roughly 37% of company revenue, and these agreements are generally terminable on 30 to 180 days’ notice. That is not an immediate existential risk, but it is a reminder that electronic-component distribution is a relationship business, not just a price business.

The VMI model with the main customer sharpens this further. It gives Astigi scheduling flexibility and a fixed spread, but it does not move the core balance-sheet risk to the other side. Inventory remains Astigi’s property, and credit risk remains Astigi’s problem. That means part of the apparent stability in the distribution engine is not risk-free stability.

Where the Advantage Still Exists

Even with all of the above, Astigi does have a real local edge. It combines engineering-led sales, available inventory, after-sales support, and the ability to design and manufacture tailored solutions. Competition in distribution is intense, including global players such as Arrow, Avnet and Future, but the ability to connect off-the-shelf components, engineering, logistics and small-to-mid-scale manufacturing under one roof still gives Astigi a useful position מול Israeli industrial and defense customers. That is a real moat, just not an untouchable one.

Cash Flow, Debt and Capital Structure

If there is one cash framing that fits Astigi best, it is all-in cash flexibility, meaning how much cash remains after actual period cash uses. The reason is straightforward: the main question here is not just whether the business can show accounting profit, but how much real room remains after dividends, investment, debt and leases.

What the Cash Picture Really Says

Operating cash flow reached NIS 32.4 million in 2025, against net profit of NIS 13.0 million. On paper that looks like excellent earnings quality. In practice, a large part of the gap came from a NIS 12.0 million release in receivables and other debtor items. The company explains this through a different fourth-quarter sales mix: only 18% of annual sales landed in the fourth quarter, versus 23% in the comparable quarter. So it would be wrong to read the full NIS 32.4 million as if it were clean recurring cash power.

At the same time, inventory actually rose by NIS 2.2 million. That reflected a NIS 3.5 million reduction in distribution inventory, offset by about NIS 5.7 million of higher raw-material and product inventory in development and manufacturing, driven by planned build for customer orders. So the company released cash on the receivables side while still tying up more cash on the production side.

The credit structure also shows that working capital will remain a real issue. Average customer days improved to 95 from 106, and that is useful progress, but it is still a long customer-credit cycle. Supplier days were only 47. That gap means that even in a good year, a meaningful part of growth still lives on the balance sheet, not only on the income statement.

Balance-Sheet Flexibility

The balance sheet itself is very comfortable. At year-end, the company held NIS 75.3 million of cash and another NIS 9.9 million of marketable securities, against NIS 5.95 million of bank debt and NIS 2.29 million of lease liabilities. The bank loans are small, fixed-rate at 2.55% to 3.10%, and amortize through 2026 and 2027. The company also has no credit lines since February 2023, simply because in the current structure it does not really need them.

That does not remove the capital-allocation question. In March 2025 the company raised about NIS 6.96 million in a private placement of 139.5 thousand shares, and in June it paid NIS 15 million of dividends. That shows balance-sheet confidence, but it also means some of 2025’s flexibility was already taken upstream to shareholders.

What this shows is a two-layer picture. On one hand, the business still generated about NIS 9.4 million of cash after investment, debt service, leases and dividends. On the other hand, the NIS 16.3 million net increase in cash was helped by the equity raise. So anyone trying to judge 2026 flexibility should keep both pictures in mind. The business does generate cash, but 2025 was not a year in which all of the cash build came purely from operations.

Outlook

Four Findings to Hold Before Reading 2026

• The balance sheet buys time, not proof. Cash gives the company room to absorb volatility, but it does not solve the quality-of-earnings question.
• Distribution did not break, but it did weaken. Distribution backlog recovered near the report date, yet segment profitability compressed hard in 2025 and especially in the second half.
• Manufacturing is already meaningful, but not yet stable. Its backlog is longer-tail and the projects look deeper, but second-half results show the move from development to serial production is still not smooth.
• There is no hard numerical target for 2026. Management talks about continued normal activity and continued investment in the production engine, but it does not give investors a clean number to monitor. The test will therefore run through deliveries, backlog, margins and cash flow rather than through a stated target.

The right way to read 2026 is as a proof year, not as a clean breakout year. On one side, the company does have a solid base. Almost the entire year-end distribution backlog, NIS 67.3 million, is meant to turn into 2026 revenue, with NIS 38.4 million already assigned to the first quarter. On the manufacturing side, NIS 43.2 million of backlog is already set for 2026. In addition, one of the rephased contracts is supposed to complete remaining deliveries in the first half of 2026, and another should bring an additional $2.6 million of advances in the first quarter.

On the other side, the market is unlikely to reward another backlog story on its own. It will look for conversion. Does the recovered distribution backlog turn back into revenue without another round of margin damage. Does the development and manufacturing segment restore a more normal profitability level after a weak second half. And does cash generation stay strong even if the receivables release seen in 2025 does not repeat.

This is exactly where created value and accessible value need to be separated. The operating value is easy to see: a growing production line, strategic customers, longer-duration backlog and a very strong balance sheet. But for that value to become accessible to shareholders, the company needs to prove two things at once: that distribution can return to more normal profitability, and that manufacturing can produce cash rather than only engineering work and backlog.

If that happens, 2026 can become the year in which the market starts to read Astigi less as a distributor with some manufacturing attached, and more as a two-engine group. If not, 2025 will look in hindsight like a year where manufacturing appeared promising, but distribution and FX still controlled the quality of the numbers.

Risks

The first and clearest risk is FX. The company did not execute any hedge transactions in 2025. At year-end it held dollar-denominated assets of NIS 61.2 million against only NIS 5.7 million of dollar liabilities. On the company’s own sensitivity table, a 5% strengthening of the shekel against the dollar would have reduced profit and equity by about NIS 3.35 million before tax. That is large enough to turn a soft quarter into a clearly disappointing one.

The second risk is concentration. Two customers generated 32% of revenue in 2025, and customer A alone reached 22%. On the distribution side, three material suppliers account for about 37% of revenue. The company does not disclose names, so it is hard to judge whether this is concentration with especially strong counterparties or concentration with a thinner margin of safety.

The third risk is backlog quality and working capital quality. Under the VMI model, the company enjoys a fixed spread and logistical flexibility, but inventory and credit risk stay on its own balance sheet. In addition, 13% of year-end distribution backlog includes orders where customers retain cancellation rights. Management says actual cancellation has been negligible, but it still means not all backlog carries the same firmness.

The fourth risk is execution through a management transition. The company is expanding headcount, especially in development and manufacturing, reinstating CEO compensation from June 2025, raising the overhead base, and at the same time replacing a long-serving CFO. None of this is alarming on its own. But in a company with a narrow management spine, it does make execution more sensitive.

The fifth risk is liquidity. This is not a business risk, but it is still a screen risk. A stock with very low daily turnover often struggles to reflect a complex thesis in a smooth way, and can overreact to narrow events even when the underlying business has not moved very much.

Conclusions

Astigi ends 2025 as a stronger operating company than the first glance suggests, but not as a cleaner one. What supports the thesis right now is a manufacturing engine that has already crossed into relevance, a backlog that recovered after year-end, and a very strong balance sheet. What blocks a cleaner thesis is that distribution still carries the group, FX remains open, and the second half proved how quickly profitability can compress. In the near term, the market will focus less on the big story and more on the pace of converting backlog into revenue, margin and cash.

Current thesis in one line: Astigi is moving from a distribution business with an attached manufacturing arm toward a two-engine group, but the transition is not complete, so distribution and FX still set the quality of the year.

What changed versus the prior read: Development and manufacturing is no longer just optionality. It has become a segment with real scale and profit, though still without the quarter-to-quarter stability that would justify ignoring distribution.

The strongest counter-thesis: The concern may be overstated, because 2025 was mainly an FX and timing year rather than a demand-collapse year. Backlog recovered quickly, and the balance sheet gives the company time to keep shifting weight from distribution to manufacturing.

What can change the market’s near-term interpretation: smooth delivery of the rephased manufacturing projects, preserved distribution margins even in a weak-dollar setting, and proof that 2026 cash flow does not depend only on timing swings in receivables.

Why this matters: If Astigi is truly moving from a dollar-sensitive component distributor toward a group with a deeper manufacturing layer, the quality of earnings and the way the market evaluates the company both change. If not, 2025 will be remembered as a timing year, not a structural one.

Over the next two to four quarters, the thesis strengthens if three things happen together: the recovered distribution backlog converts into revenue without another margin reset, the manufacturing backlog turns into delivery and profitability that is better than the second-half level, and cash flow stays positive without another unusually large receivables release. It weakens if the company goes into another round of delivery deferrals, if dollar weakness keeps eroding profit faster than operating improvement can offset it, or if customer concentration keeps rising without better transparency.